Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance Database

<b>Background</b>: Clinical trials comparing novel oral anticoagulants (NOACs) with warfarin reported a lower mortality rate and a reduced incidence of bleeding with NOACs. However, these studies do not allow for final conclusions about safety. Moreover, direct comparisons among NOACs are not availa...

Descripció completa

Dades bibliogràfiques

Autors principals:	Pier Paolo Olimpieri, Fanny Erika Palumbo, Gaetano Giuffrida, Edoardo Milanetti, Cecilia Gozzo, Elisa Lucia Scebba, Giovanni Luca Romano, Giovanni Enrico Lombardo, Andrea Duminuco, Calogero Vetro, Davide Giuseppe Castiglione, Giuseppe Alberto Palumbo, Salvatore Scarso, Filippo Drago, Lucia Gozzo
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2025-10-01
Col·lecció:	Hematology Reports
Matèries:	novel oral anticoagulants Vitamin K Antagonists adverse events EudraVigilance safety
Accés en línia:	https://www.mdpi.com/2038-8330/17/5/54
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!